Delivery Order SPE2DB24D2205-SPE2DB25FDYNC

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,339.92 firm fixed-price delivery order is for the supply of 4564858692 - VERAPAMIL 5 MG/2 ML VIAL 2ML, a cardiovascular medication. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,108.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC), is for the supply of Verapamil 5 mg/2 ml vials. There is no set-aside designation for this award. The IDC held by Amerisourcebergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,980.40 firm fixed price contract is for the delivery of VERAPAMIL 5 MG/2 ML VIAL 2ML, a cardiovascular medication, with a performance period through February 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 that...
This federal contract award, valued at $1,075.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of 4566872727 units of VERAPAMIL 120 MG TABLET 90S, a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,596.20, is for the delivery of verapamil 5 mg/2 ml vials. The contract has a completion date of February 19, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with an ID of SPE2DB20D7059|SPE2DB25FPWG3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.70, is for the delivery of 4566678715 - VERAPAMIL 80 MG TABLET 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 12, 2024. This award is...
This federal contract award, valued at $1,186.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The award is a firm fixed price delivery order for 4,563,955,979 vials of Verapamil 5 mg/2 ml, a cardiovascular medication. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to...
This federal contract award, number SPE2DB20D2002|SPE2DB22FL09P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,205.37 delivery order is for the supply of 4,555,797,600 Verapamil ER 120 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical through November 2026. The IDC enables the company to...
This federal contract award, valued at $3,370.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Verapamil ER PM 300 mg Capsules, a cardiovascular medication, with a completion date of January 27, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This federal contract award, valued at $2,853.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Verapamil ER PM 100 mg capsules, a cardiovascular medication, with a period of performance through August 2024. The contract utilizes a Firm Fixed Price pricing structure and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYNC
    Delivery Order

This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDYNC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,051.76, is for the delivery of Verapamil 5 mg/2 ml vials, a cardiovascular medication.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/21/25, 10:15 AM